2007
DOI: 10.1007/s11060-007-9361-z
|View full text |Cite
|
Sign up to set email alerts
|

Atypical teratoid/rhabdoid tumor arising in the setting of a pleomorphic xanthoastrocytoma

Abstract: We present a case of a 23-year-old man with a tumor containing glial and rhabdoid elements where the former had features of a pleomorphic xanthoastrocytoma (PXA) and the latter had the immunophenotype and genetic profile of an atypical rhabdoid/teratoid tumor. The patient presented with a short history of raised intracranial pressure with rapid deterioration in sensorium. He had a poor outcome despite surgery and radiotherapy. We report this case because of its unusual presentation in adulthood and its occurre… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

6
46
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 69 publications
(52 citation statements)
references
References 20 publications
6
46
0
Order By: Relevance
“…Anaplastic astrocytoma in a 22-month-old child was reported [9], which recurred 4 years after the first occurrence and demonstrated histological features and immunohistochemical staining patterns that were consistent with AT/RT; this tumor also showed loss of INI1 expression. The other report was of a 23-year-old man with a tumor containing glial and rhabdoid elements, where the former had features of pleomorphic xanthoastrocytoma and the latter the immunophenotype and genetic profile of AT/RT [38]; the tumor presented rapid progression and deteriorated despite radical surgery and radiotherapy. The last case was a pilocytic astrocytoma in an 18-month-old child [44], which recurred dramatically 9 years after the initial presentation and demonstrated a ganglioglioma that had developed an AT/RT component.…”
Section: Discussionmentioning
confidence: 99%
“…Anaplastic astrocytoma in a 22-month-old child was reported [9], which recurred 4 years after the first occurrence and demonstrated histological features and immunohistochemical staining patterns that were consistent with AT/RT; this tumor also showed loss of INI1 expression. The other report was of a 23-year-old man with a tumor containing glial and rhabdoid elements, where the former had features of pleomorphic xanthoastrocytoma and the latter the immunophenotype and genetic profile of AT/RT [38]; the tumor presented rapid progression and deteriorated despite radical surgery and radiotherapy. The last case was a pilocytic astrocytoma in an 18-month-old child [44], which recurred dramatically 9 years after the initial presentation and demonstrated a ganglioglioma that had developed an AT/RT component.…”
Section: Discussionmentioning
confidence: 99%
“…[3238] Adult cases are rare and, as far as we are aware, only 42 cases have been reported to date [Table 1]. [2345910111213141516171821232425262729303133343536373941] Furthermore, there are only seven adult cases arising in the sellar turcica described in the literature. [224253034]…”
Section: Introductionmentioning
confidence: 99%
“…A multistep malignant transformation of a preexistent benign nervous lesion. In this hypothesis, the rhabdoid features would be secondarily acquired from a primary nonrhabdoid proliferation by the biallelic inactivation of SMARCB1, as described in other glial tumors 1,12 and as suggested by Carter et al 11 in PNS. This hypothesis of a multistep tumoral evolution might account for the long delay between first neurological symptoms and diagnosis observed in some patients.…”
Section: Discussionmentioning
confidence: 86%
“…Mean age at diagnosis was 6.6 years (range, 0 to 45 y), and the diagnosis was made before 12 Eight patients presented at diagnosis with neurological symptoms lasting for several months (up to 1 y; Supplementary Figure 1, Supplemental Digital Content 1 http://links.lww.com/PAS/A117). In these cases, the diagnosis of RT was not primarily suggested because of atypical location or slow-growing behavior (Table 1).…”
Section: Clinical Featuresmentioning
confidence: 99%